SARS-COV-2 VIRUS INDUCES THE BUILDINGOF HLA CLASS I AND CLASS II ANTIBODIES IN RECOVERED COVID-19 PATIENTS

被引：0
|
作者：
Dada, Ashraf [1 ]
Alsuraihi, Osama [1 ]
Bayumi, Daniyah [1 ]
Dada, Tarek [1 ]
Alhassan, Khalid [1 ]
机构：
[1] Paul Keown Univ British Columbia, Vancouver, BC, Canada
来源：
HUMAN IMMUNOLOGY | 2020年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P212
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [1] SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
    Dada, Ashraf
    Elhassan, Khalid
    Bawayan, Rayan Mohammed
    Albishi, Ghadeer
    Hefni, Lama
    Bassi, Sawsan
    Sobahy, Turki
    Cupler, Edward
    AlBaz, Nabeela
    Wali, Ghassan
    Alraddadi, Basem
    Alshukairi, Abeer N.
    [J]. INTERVIROLOGY, 2022, 65 (04) : 230 - 235
  • [2] Screening for antibodies to HLA class I in apheresis donors following Covid-19 or SARS-CoV-2 vaccination
    Nissen-Meyer, Lise Sofie H.
    Czapp, Elzbieta
    Naper, Christian
    Jensen, Tore
    Boulland, Line M. L.
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2022, 61 (05)
  • [3] Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
    Weidner, Lisa
    Kalser, Julia
    Kreil, Thomas R.
    Jungbauer, Christof
    Mayr, Wolfgang R.
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021, 48 (03) : 173 - 174
  • [4] Plausible Influence of HLA Class I and Class II Diversity on SARS-CoV-2 Vulnerability
    Sharma, Neha
    Sharma, Gaurav
    Toor, Devinder
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2024, 44 (01) : 31 - 40
  • [5] Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
    Nagler, Adi
    Kalaora, Shelly
    Barbolin, Chaya
    Gangaev, Anastasia
    Ketelaars, Steven L. C.
    Alon, Michal
    Pai, Joy
    Benedek, Gil
    Yahalom-Ronen, Yfat
    Erez, Noam
    Greenberg, Polina
    Yagel, Gal
    Peri, Aviyah
    Levin, Yishai
    Satpathy, Ansuman T.
    Bar-Haim, Erez
    Paran, Nir
    Kvistborg, Pia
    Samuels, Yardena
    [J]. CELL REPORTS, 2021, 35 (13):
  • [6] HLA class I and class II polymorphisms are associated with mortality, hospital admission and poor anti-SARS-COV-2 IGG response in patients with COVID-19
    Nino, Jairo
    Carmen Martin, M.
    Nieves Gutierrez-Zufiaurre, M.
    Alcoceba, Miguel
    Garcia-Alvarez, Maria
    Carmen Chillon, M.
    Eugenia Alonso, M.
    Jimenez, Cristina
    Medina, Alejandro
    Terradillos-Sanchez, Pilar
    Gonzalez-Calle, Veronica
    Luis Munoz, J.
    Gonzalez, Marcos
    Garcia-Sanz, Ramon
    Boix, Francisco
    [J]. HLA, 2022, 99 (05) : 525 - 526
  • [7] Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19
    Hoang, Van T.
    Dao, Thi L.
    Gautret, Philippe
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2366 - 2367
  • [8] Effect of COVID-19 Vaccination on the Levels of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Naive, Hybrid, and Breakthrough SARS-CoV-2 Recovered Indian Individuals
    Deepika, Gujjarlapudi
    Adarsh, Singamsetty
    Sadhana, Yelamanchili
    Srihitha, Mahavadi
    Veeraiah, Namburu
    Reddy, Duvvur Nageshwar
    [J]. JOURNAL OF LABORATORY PHYSICIANS, 2023, 15 (03) : 377 - 382
  • [9] Detection of antibodies against SARS-CoV-2 in patients with COVID-19
    Du, Zhe
    Zhu, Fengxue
    Guo, Fuzheng
    Yang, Bo
    Wang, Tianbing
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1735 - 1738
  • [10] Impact of SARS-CoV-2 RNA titer on the level of IgG antibodies in recovered patients with COVID-19 disease
    Abdullah, Zhiman Mohammed
    Goreal, Amer Abdalla
    Abdo, Jasim Mohammed
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (04): : 432 - 438
12345